SpineSmith Partners, a Texas-based medical device company, has received FDA clearance for the VisuALIF interbody fusion implant system, according to a company news release.
The VisuALIF is a two-piece, standalone device for use during intervertebral body fusion of the lumbar spine. The device is open-faced, allowing in situ graft placement, tactile feedback with a face plate attachment and device placement flush with the anterior aspect of the vertebrae.
The device is available in several product sizes and configurations designed to accommodate for a wide spectrum of patient anatomy.
Read the SpineSmith Partners news release on VisuALIF.
Read other coverage on new spine devices:
- Wenzel Spine Receives FDA Clearance on Spinal System
- ArthroCare Receives FDA Clearance for Vertebral Augmentation Device
- Orthofix Releases Spinal Deformity Correction Product
The VisuALIF is a two-piece, standalone device for use during intervertebral body fusion of the lumbar spine. The device is open-faced, allowing in situ graft placement, tactile feedback with a face plate attachment and device placement flush with the anterior aspect of the vertebrae.
The device is available in several product sizes and configurations designed to accommodate for a wide spectrum of patient anatomy.
Read the SpineSmith Partners news release on VisuALIF.
Read other coverage on new spine devices:
- Wenzel Spine Receives FDA Clearance on Spinal System
- ArthroCare Receives FDA Clearance for Vertebral Augmentation Device
- Orthofix Releases Spinal Deformity Correction Product